Research programme: biodefence therapeutics - Callisto

Drug Profile

Research programme: biodefence therapeutics - Callisto

Alternative Names: 6343 peptide; Anti Toxic Shock antibody - Callisto; ATS antibody - Callisto; Biodefense therapeutics - Callisto; TSS Mab

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Callisto Pharmaceuticals
  • Developer Synergy Pharmaceuticals Inc
  • Class Monoclonal antibodies; Peptides; Vaccines
  • Mechanism of Action T cell activation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Staphylococcal infections; Streptococcal infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Staphylococcal-infections in USA
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Streptococcal-infections in USA
  • 17 Jan 2013 Callisto Pharmaceuticals has been merged into Synergy Pharmaceuticals Inc
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top